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P R E S E N TA C I Ó N
En la presente tesis, utilizamos simulaciones de dinámica molecular (DM)
clásica y potenciales basados en la estructura para estudiar cambios conforma-
cionales de gran escala en proteínas. Se propone un esquema computacional
capaz de reproducir este tipo de desplazamientos y que permite realizar cálcu-
los de energía libre compatibles con las capacidades actuales de cómputo.
La posibilidad ofrecida hasta la fecha por los métodos de biofísica computa-
cional es simular hebras macromoleculares como dominios de proteínas quinasa
determinados con alta precisión física y en detalle atómico. Sin embargo, es-
tos métodos presentan importantes limitaciones, que reducen los sistemas de-
scriptibles a estructuras largas de apróximadamente 300 residuos (teniendo en
cuenta recursos computacionales estándar para cálculos de energía libre). Para
superar estas limitaciones, añadimos a nuestro potencial un término basado
en la estructura. Este término reduce el coste computacional de la simulación,
si bien supone una pérdida de precisión. Dicha innovación metodológica per-
mite alcanzar la reproducción de transiciones conformacionales de gran escala
y posibilita la extracción de datos de energía libre. Específicamente, nos per-
mitió la simulación de una cadena de la proteína quinasa c-Abl de hasta 450
residuos.
En los siguientes capítulos describiré cómo se implementó este esquema com-
putacional y los resultados que se obtuvieron con el mismo. En el primer
capítulo presento los conocimientos previos que inspiraron el modelo. En
el segundo capítulo describo como se implementó este esquema, tratando la
relación entre pérdida de precisión y ganancia en eficiencia, y en el tercero su
validación en el plegamiento de pequeñas proteínas. Concluyo ilustrando en
el cuarto capítulo la aplicación de este protocolo en el caso de la proteina c-Abl
y, finalmente, los resultados obtenidos con este sistema y la discusión de los
mismos.
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I N T R O D U C T I O N
1.1 conformational transitions in proteins
In this work, we use classical molecular dynamics simulations and structure-
based potentials to study large-scale conformational changes in proteins. We
propose a computational scheme able to reproduce such motions within the
current computational capabilities that can be used for free energy calculations.
The interest of this investigation is both clinical and fundamental. On the one
hand it contributes to the mechanistic understanding of the regulation of mul-
tidomain proteins whose dysregulation is associated to human cancer like in
the case under study, the c-Abl protein kinase. On a more foundational front,
this protocol provided us with the chance to investigate protein conformational
changes ranging from angstroms to tenths of nanometers, rarely accessible to
current average computational capabilities, reaching a closer depiction of pro-
tein dynamics and mechanicism at the mesoscopic scale.
Proteins are a fundamental category of macromolecules within the realm of
living matter. They are responsible of performing a plethora of functions that
are indispensable to the life of cells and organisms. Among them, enzymes
are catalyst proteins: they lower the activation energy of a specific biochemical
reaction, increasing its rate without being consumed by it. For many enzymes,
scientists were able to identify amino acids directly involved in catalytic activ-
ity (for an example, see [1]). This led to the notion of associating the phases of
an enzyme’s activity and regulation to specific structural conformations.
Computational methods of atomistic resolution such as molecular dynamics
(MD, [2, 3]) can be extremely valuable in characterizing these conformations
and help to quantify the accessibility of the conformational states involved in
enzymatic function.
In a typical framework of classical MD, a protein is represented as a set of
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N bound atoms whose position is specified by 3N coordinates and evolves
in time according to a physically accurate potential. Different conformations
occupy different positions in the 3N dimensional free energy space and are
separated by barriers, whose disparate heights define a landscape. Molecular
simulations (MD and derived enhanced sampling methods - for reference see,
for example, [4]) are capable of estimating the free energy profile along general-
ized coordinates chosen from this multidimensional landscape and to provide
insights on the structural elements involved in conformational barrier crossing
and, more generally, into protein function.
Because of the value they add to the description of living matter at the atomistic
level, molecular simulations are now recognized as powerful tools for the un-
derstanding of any phenomenon where biomolecules are involved. The sharp-
ness of their vision greatly helps in cases that see subtle deviations from the
wild-type protein at play, like clinical mutants. In fact, the polypeptide chain
that builds up a wild-type protein can be modified by single residue mutations
or larger erroneously transcribed strands, or both, and in some cases develop
in the molecular mechanism governing a malignant cell. As will be described
briefly in the next section, this is the case of c-Abl protein and of its variations
that drive certain forms of leukemia: the Bcr-Abl fusion protein and its clinical
mutants.
The main task of molecular simulations is to generate the ensemble of con-
formations that corresponds to a specific system and set of thermodynamic
conditions in agreement with the laws of statistical mechanics. Once a reliable
ensemble has been generated by the simulation, new knowledge about the
system can be gained through the ensemble’s extremum principle: a thermo-
dynamic law involving an observable such as entropy and free energy whose
maxima or minima (extrema) indicate the states of equilibrium and how the
system most likely tends to reach them. For transitions in the canonical ensem-
ble (NVT), the extremum principle refers to the Helmholtz free energy, so this
quantity becomes cardinal to the characterization of a system at equilibrium.
Moreover, being the free energy a peculiar property of the specific system, any
modification in the protein and its environment must be reflected on its free
energy landscape. Consequently, perturbations in the physiological free energy
profile can be exploited as a detection tool, as they may indicate important al-
terations of the equilibrium state and be part of the molecular picture behind
a pathologically misbehaving protein.
2
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1.2 the case of c-abl
The c-Abl protein is a non-receptor tyrosine kinase, a modular signaling pro-
tein involved in cell differentiation, cell division, cell adhesion and stress re-
sponse [5]. As a kinase, it catalyzes phosphate transfer onto protein substrates.
Its catalytic domain is tightly regulated through the interplay of several struc-
tural intra- and interdomain interactions that determine its degree of autoin-
hibition, and exhibits low constitutive catalytic activity due to tight regulation
[6].
Bcr-Abl is associated to more than 90% of the cases of chronic myelocytic
leukemia, CML [7], and to one third of the cases of acute lymphocytic leukemia,
ALL [8]. It is a chimeric protein encoded by an abnormal chromosome (the so-
called “Philadelphia chromosome”) that includes only part of the gene that
expresses c-Abl. The consequence is that Bcr-Abl shares with c-Abl the cat-
alytic domain, but not the rest of its endogenous regulatory domains [9]. It
exhibits constitutive catalytic activity and is considered necessary for inducing
cell transformation and cause malignancy [10].
From a free energy landscape standpoint, Bcr-Abl can be interpreted as a sys-
tem that, in its irregular layout, admits differently distributed populations of
active and inactive conformations of the catalytic domain with respect to its
physiological counterpart c-Abl and, because of this, reproduces the signaling
effect pertaining to c-Abl in aberrant proportions. Full understanding of the
molecular reasons behind this ability of Bcr-Abl is a subject of research and
would greatly help the design of inhibitors for the treatment of different forms
of leukemia in humans. Gaining quantitative information on which portions
of the protein and of the free energy landscape in c-Abl (and indirectly of Bcr-
Abl) are correlated and relevant for function is currently a highly non-trivial
endeavor and is one of the subjects this thesis addresses.
The c-Abl kinase protein is not an isolated case for its role in cancer devel-
opment among the kinase family.
All protein kinases act as switches by catalyzing phosphoryl transfer from ATP
to protein substrates [11]. Because of their power to modify substrate activity
through phosphorylation (the most abundant form of post-translational mod-
ification and cellular regulation in eukaryotes), they intervene in most of the
signal transduction processes in eukaryotic cells. Additionally, they participate
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in metabolism, transcription, cell cycle progression, and other cellular vital
functions. They turn on and off cell signaling pathways and for this reason the
balanced regulation of their catalytic domain - realized by differentiated sets of
adaptor proteins - is of utmost relevance [12]. Their action is counterbalanced
by the family of phosphatases, in charge of removing the phosphoryl group
from phosphorylated residues.
Soon after the publication of the sequence of the human genome [13], and
thanks to the availability of several information sources for human sequences,
a number of 518 putative protein kinase genes was estimated via sequence
analysis, accounting for about 1.7% of the entire human genome [11]. For their
strategic role in cytoplasmic signaling, kinases can often represent vulnerable
points of their signaling pathway, and their drift from a properly regulated
condition can assume pathological consequences.
For their role of switches, kinases not only are vulnerable to pathological dys-
regulation but, at the same time, offer the chance of a possible therapy. In fact,
targeting a malignant kinase for selective inhibition has demonstrated highly
promising over the last fifteen years.
A brilliant example of this strategy in the history of pharmacological research
is exactly Bcr-Abl with its first inhibitor, the cancer drug imatinib (also known
as Gleevec or Glivec). The approach behind imatinib pharmacological devel-
opment was one of rational drug design [14], targeted to specifically inhibit
the Bcr-Abl fusion protein at the active site. Imatinib has shown IC50 values
ranging between 0.1 and 0.5 µM for c-Abl, v-Abl and Bcr-Abl kinase inhibition
and three orders of magnitude lower values on other closely related kinases
such as c-Src, EGFR, c-Lyn, PKA and others [15]. Soon after running clini-
cal trials that resulted in minimal adverse effects and complete hematologic
remission in 53 over 54 patients [16], the pharmaceutical company Novartis an-
nounced the United States FDA approval for imatinib through oral therapy for
the treatment of patients with chronic myeloid leukemia (CML). Along with
its second-generation inhibitors [17, 18], the rationally designed inhibitor ima-
tinib is now a clinical reality. In addition, its efficacy represents a powerful
proof of concept for rational drug design as an effective pharmacological strat-
egy, when tailored to molecular abnormalities associated to a human disease.
Yet, mutations in the kinase domain often give rise to drug resistance at later
stages of the disease, so these inhibitors do not represent the definitive answer
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yet. They are necessary but not always sufficient to keep the disease under con-
trol. Thus, the need for fully unraveling the molecular regulation mechanism
of this molecule remains, and with it the hope of finding a conclusive set of
inhibition strategies, possibly including allosteric sites. Current inhibitors, in
fact, all bind at the active site. Thus, most of them are rendered inactive by
the same resistance mutations. Therefore, inhibitors targeting allosteric sites
would be of great value [19].
Considered the large physiological impact of the kinase family, the potential of
selective kinase inhibition is still far from depletion and holds the promise of
new breakthroughs [20].
The chance offered today by computational biophysics methods is to simu-
late macromolecular strands like specific kinase domains with high physical
accuracy (through classical force field MD) and in atomistic detail. A compu-
tational insight of this kind can help ground experimental choices in physico-
chemical bases and save time and expensive and complex experimental efforts
for the most promising routes. In the following chapter, I will describe the
computational strategies we applied with the aim of providing an efficient and
comprehensive structural intepretation for the malignant drift of c-Abl.
1.3 computational limits
Although state-of-the-art computational simulations for biomolecules have given
important insights, there is currently a series of strong limitations to the results
within reach of these methods.
One limiting factor is the energy barriers’ height that hinder conformational
sampling. In classical or replica exchange MD (REMD from now on) simula-
tions, that are based on Boltzmann sampling, the only chance a system has
to overcome a barrier is an energy fluctuation, whose probability decreases
exponentially with the barrier’s height. Thermally high barriers often shield
phenomena of biological interest but in the community their crossing is de-
fined, for its technical difficulty, a “rare event”. Practically, just this notion
severely limits the phase space accessible to a simulated system within the bar-
riers whose height it is unlikely to repeatedly overcome.
Beyond the ruggedness and the extent of the landscape to sample, a second
notion to consider when designing a computational experiment lies in the com-
bination of the total computational power at disposal and the system size. The
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computational power, namely the simulation time per CPU available to the
user for her simulations, is the most tangible practical limit to every in silico
experiment. Typically, in a standard computer cluster like the ones at disposal
for most of the present work, computational power allows - at optimal scal-
ing - to simulate about a thousand atoms per CPU for one microsecond in a
few months [21]. Notable exceptions to this average estimate exist. They pro-
duced [22, 23, 24] and will keep producing new remarkable insights on longer
timescales, but they remain uncommon.
Since convergence of the sampling to equilibrium is required for drawing any
grounded conclusion and computational load is the principal practical limit,
care has to be given for convergence to be reached in a reasonable time for a
given system size. These limitations concur to set quite restrictive limits to the
phenomena accessible to molecular simulations with classical force fields.
For these reasons, to achieve the aim of simulating large-scale conformational
transitions on proteins and protein complexes much larger than 300 amino
acids (the approximate size of the kinase domain) with general-purpose com-
putational resources, classical force field MD or REMD simulations with ex-
plicit solvent are not currently a viable choice. These methods rely, for the
future, on the advance of computational power to afford such goal.
In the meantime, the request for methodological alternatives encouraged the
exploration of new ways to tackle the rare events problem. Two possible paths
leading to easier access to such events are: 1) acting on the front of the sam-
pling method, going beyond Boltzmann sampling, and 2) acting on the front
of the potential energy function describing the interactions between atoms, by
reducing the force field complexity.
In this work, metadynamics [25] was the enhanced sampling method of choice.
Its implementation PLUMED [26], provides the user with the tools to define a
reduced number of generalized coordinates in the free energy landscape and
drive the system over the transition barriers along these coordinates. These
tools and the combination with a replica exchange scheme have been a funda-
mental ingredient for succeeding in the simulation of c-Abl’s large-scale transi-
tions.
Still, although enhanced sampling methods increase the accessible configura-
tion space, the size of the system and the amplitude of the conformational
transitions are still a limiting factor. To overcome it, we combined the most
powerful sampling methods at our disposal with a boost at the force field level,
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by combining a structure-based term with a state-of-the-art classical force field.
The next chapter will describe this protocol in detail, preceded by some back-
ground notions that wish to help situate the different approaches involved.
The model was first tested and tuned to the folding transitions of two small
proteins, one of which rich in α helices and the second in β sheets: the villin
headpiece HP35 and c-Src SH3 domain. This was made in order to calibrate
the free parameter of the model (the energy per native contact, ε, in kJ/mol) on
a representative benchmark, so to ensure physical reliability in relation to the
description of the two major structural elements occurring in protein structure.
Chapter 3 describes and discusses this validation phase of the work.
Chapter 4 illustrates the application of the protocol to c-Abl, by first intro-
ducing in detail the molecular features most relevant to this work, and finally
the results obtained and their discussion.
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C O M P U TAT I O N A L M E T H O D S
Large-scale conformational transitions in proteins still remain beyond the reach
of unbiased explicit-solvent MD simulations. Since this was our ultimate tar-
get, many measures had to be orchestrated to hit it. Not only the structure-
based nuance was a fundamental character of our pipeline, but also enhanced
sampling methods were required. At this level, only parallel tempering meta-
dynamics (PTmetaD) was capable of attaining meaningful results on the appli-
cation front.
This chapter will describe the methods employed in this thesis to study folding
and large-scale conformational transitions. It starts from a brief description of
molecular dynamics and the other enhanced sampling methods we employed
to overcome current sampling limitations. The next part illustrates the back-
ground and the reasons of structure-based modeling. Finally, it reports the
methodological details of the structure-based model that this thesis presents.
2.1 sampling methods
2.1.1 molecular dynamics
In this work, proteins and peptides (and, in some cases, their solvent too) are
treated according to classical molecular dynamics, namely as fixed sets of N
bound atoms whose position is specified by 3N coordinates. These coordinates
collectively define a conformation, and it is assumed that no bond is created
or broken during the simulation. The technique of all-atom classical molecular
dynamics estimates numerically the forces acting on atoms and the consequent
displacements they induce by assuming a potential energy function partitioned
in five terms, three referred to interactions between bonded atoms and two rel-
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ative to nonbonded interactions, computationally more expensive.
U = Ubonds +Uangles +Udihedrals︸ ︷︷ ︸
bonded interactions
+ULJ +Uelectrostatics︸ ︷︷ ︸
nonbonded interactions
= ∑
i,j∈ b
1
2
Kb, ij(r− r0)2 + ∑
i,j∈ b
1
2
Kϑ, ij(ϑ− ϑ0)2
+ ∑
i,j∈ b
∑
n
Kn[1− cos(Cnϕ+ δn)]
+ ∑
i,j∈ nb
ε ij
( r0ij
rij
)12
− 2
(
r0ij
rij
)6+ ∑
i,j∈ nb
partial charges
KC
qiqj
rij
(2.1)
where, for the atom pair i,j:
• Kb, ij is the force constant and r0 the equilibrium distance for the bond of
length r;
• Kϑ, ij is the force constant and ϑ0 the equilibrium angle for the angle ϑ;
• the dihedral angle ϕ is modeled as a periodic function with n barriers
defined by the parameters Kn, Cn and δn;
• ε ij is the depth of the well placed at r0ij for the Lennard-Jones interaction
at distance rij;
• qi and qj are the respective partial charges at distance rij and KC is the
electric conversion factor over the dielectric constant.
While the computational biophysics community mostly uses this functional
form, the parameters vary from one force field to another. The force field’s co-
efficients depend on the nature of atoms and bonds involved and are derived
by fitting on ab-initio calculations and experiments. In the effort of establishing
a reference for the community, different state-of-the-art force fields (Amber ff03
[27], Amber ff99SB*ILDN [28, 29, 30], CHARMM22 [31] with the CMAP back-
bone correction [32], and a version of CHARMM22 with modified backbone
torsion potentials) were recently tested on a common benchmark, the folding
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of a small helical protein, with the exceptional computing means available at
D.E. Shaw Research [33]. The comparison led to conclude that the overall per-
formances of these recently developed force fields under test were consistent
and successful in recovering the correct native state and folding rate. Yet, space
for improvement remained in many respects.
Given a fundamental discretized time unit called time step, forces in MD are cal-
culated from the classical Hamiltonian via Newton’s second law of dynamics,
the positions are updated and forces recalculated, recursively. Thus, MD pro-
vides dynamical information for the system under study in compliance with
the fixed ensemble variables. These conditions, in turn, are enforced through
constraints, thermostats or barostats that affect the computing of forces. Fur-
thermore, if a trajectory conformed to the ergodic hypothesis (that all acces-
sible microstates were equiprobable during the sampling), the average over
the trajectory could be assumed equivalent to the average on the phase space
ensemble, which gives to MD the feature of yielding also ensemble averages,
besides the dynamical information.
The current standards for systems sizes and investigated biological phenomena
are the result of the dominant practice in the community to use MD engines
from software simulation packages for biomolecular simulation on parallel ma-
chine. Popular packages are AMBER [34], CHARMM [35], NAMD [36, 37] and
GROMACS [38, 39, 40, 41].
2.1.2 parallel tempering
Parallel tempering is a sampling method in which a set of N temperatures
is assigned to different molecular dynamics simulations of the same system.
It is a form of replica exchange MD (REMD). The rationale for accelerating
standard MD sampling here is that high-temperature replicas are capable of
crossing energy barriers more easily than the low temperature ones, which in
turn are more likely to sample the local minima they happen to occupy. In
parallel tempering, a number N of MD simulations are started in parallel at
temperature T1 < T2 < · · · < TN . Periodically, an exchange of coordinates is
attempted between a neighboring pair of configurations i, i+1. The acceptance
probability of this move is:
P(1↔ 2) = min
(
1, exp
[(
1
kB T1
− 1
kB T2
)
(U1 −U2)
])
(2.2)
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This yields an overall enhancement of efficiency in the sampling, which re-
mains of Boltzmann type [42, 43].
2.1.3 metadynamics
One of many methods aiming to provide a solution to the rare events problem,
metadynamics (metaD from now on, [25]) detaches from Boltzmann’s sampling
by applying to a system’s potential an additional time-dependent term on a
subset of the total degrees of freedom.
Metadynamics’ core idea [44] finds its roots in the concepts of dimensionality
reduction (pioneered by Y. Kevrekidis and coworkers [45, 46]) and shares some
similarities to tabu search, umbrella sampling, conformational flooding and the
local elevation method [47]. In its scheme, a subset of the whole free energy
space is defined by the choice of a set {s} of a reduced number of generalized
coordinates (usually referred to as collective variables, CVs).
To understand the basic picture, let us first consider a definition that turns
fundamental in the realm of free energy calculations. In an unbiased MD
simulation for a canonical system, the Helmholtz free energy is defined, up to
an additive constant, by
F(s) = − 1
β
ln N(s) (2.3)
where N(s) is the number of visited configurations at the point s of the CV
space. These CVs are functions of structural elements of the system, and rep-
resent the transition’s order parameter (so to concisely describe and discrimi-
nate between different configurations for the event under investigation). In the
actual cases examined in the following of this thesis, the CVs chosen were dis-
tances (between either single atoms or centers of mass) and contact map-based
s-paths (see below for more details).
The metaD potential contains a bias term that is built adaptively at regular
time intervals. In the spirit of umbrella sampling [48], metaD generates the en-
semble associated to a known bias V(s) and recovers the free energy through
the formula
F(s) = − 1
β
ln N(s)−Vbias(s) (2.4)
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At a fixed time stride τG, an N-dimensional gaussian is added to the potential
at the system’s coordinate, in order to force it to move away from the local
minimum of the N-dimensional free energy landscapes where it is placed in.
At time t, the metaD bias potential has the following form:
Vbias(s, t) =
∫ t
0
dt′ω exp
(
−
d
∑
i=1
(si(q)− si(q(t′))2
2σ2i
)
, (2.5)
where d is the number of collective variables, σi is the width of the gaussian in
the i-th direction and ω has the dimension of an energy rate. The parameters
are strongly system dependent and must be assigned opportunely by the user.
This mechanism enhances the probability of barrier crossing from exponen-
tial (as in Boltzmann’s sampling) to linear in the barrier high. The response
of the system along the trajectory to the bias potential builds up the time-
dependent, landscape-adaptive potential, provided the systems has the time
to diffuse towards the new free energy minimum (gaussians have to be de-
posited at moderate stride to ensure this). At convergence the system will have
eventually escaped any minimum it may be trapped in, and in the case of well-
tempered metadynamics it can be mathematically proved that the underlying
free energy profile is reconstructed by integrating the bias potential [49].
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Generalized coordinate (collective variable)
Figure 1: Mechanism of gaussian hills addition in metaD.
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The computational implementation of metadynamics was provided by the pub-
licly available PLUMED software package [26]. PLUMED also implements
several auxiliary developments that were designed to enhance the basic and
powerful sampling scheme described above. Here we mention and syntheti-
cally describe in principle those involved in the original work we present, and
redirect to the suggested references for further details.
• One of the most relevant metaD improvements we resorted to is well-
tempered metadynamics [50]. The well-tempered rationale significantly
refines basic metaD by defining the bias potential V(s, t) as a monoton-
ically increasing function of the histogram N(s, t) of the CV values at
the same time, thus embedding in the bias potential a term that discour-
ages already visited configurations by construction. Specifically, the time-
dependent potential of well-tempered metaD has the form:
V(s, t) = ∆T ln
(
1+
ωN(s, t)
∆T
)
(2.6)
where ω is an energy rate and ∆T is a characteristic energy. This choice
implies a damping, time-dependent factor for the height w of the de-
posited gaussian: w = ωe−V(s,t)/∆T τG and convergence of the bias poten-
tial
V(s, t→ ∞) = − ∆T
∆T + T
F(s) (2.7)
to the exact free energy in the long time limit. This provides the simu-
lation with a sort of adaptive brake that prevents an idle bias to grow
(and the simulation to keep running) idly over a flattened free energy
surface, at variance with the original metadynamics recipe, that features
a fixed height for the gaussian hills and leads to bias potentials that grow
indefinitely. The PLUMED user will additionally specify the bias factor
(T + ∆T)/T. This result found several empirical confirmations and was
analytically proven for systems driven by Langevin dynamics [51].
• Just as the REMD approach was developed for MD calculations, the same
scheme was devised for metaD. This is called Parallel Tempering meta-
dynamics (PTmetaD, [52]). Taking into account the fact that each parallel
simulation i is in the act of building its own bias Vi(s), the acceptance
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probability between two adjacent replicas i and j for PTmetaD can be
shown to be:
P(i↔ j) = min
{
1, exp
[(
1
kB Tj
− 1
kB Ti
)
(U(sj)−U(si))
+
1
kB Ti
(Vj(sj)−Vj(si)) + 1kB Tj (Vi(si)−Vi(sj))
]}
(2.8)
The result is a boost at two levels in the sampling enhancement with re-
spect to classical MD. When used in this thesis, PTmetaD had resulted
the only viable solution after reiterated tentative applications of less pow-
erful approaches such as single metaD or REMD.
• Furthermore, when it comes to conformational transitions in proteins, a
non-reductive way of describing a macromolecular transition is highly de-
sirable. Such need was addressed with the implementation of path collec-
tive variables, adapted to metaD by Branduardi et al. [53]. PLUMED im-
plements two kinds of path CVs, the s-path and z-path. Their advantage is
to compactly represent global configurations and connect them through
an ordered path based on their distance d(si, sj), where d : X × X → R+0
is a metric on X. PLUMED offers various possibilities for the metrics d,
and in this work the choice fell on the contact-map based metric. It con-
sists in the distance between the contact matrices D for a given subset of
the atoms in the system, so that d(Xj, Xi) = ||D(j) − D(i)|| with
Dab(X) = θ(cab − rab)wab
(
1− (rab/r(0)ab )nab
)
(
1− (rab/r(0)ab )mab
) (2.9)
where θ(r) is a step function which vanishes if r < 0 and r(0)ab , nab and mab
are flexible parameters. The definition of a path-based CV requires also
the choice of an ordered set of a number R of reference conformations,
representative of the extremes and relevant intermediates of the transi-
tion to describe. Two are the variables that can be monitored along the
simulation:
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– The position of the system along the path:
s = Z−1
N
∑
i=1
ie−λ d(Xi ,X(t))
where
Z =
R
∑
i=1
e−λd(Xi ,X(t))
is a normalization factor and d(t) defines the distance between the
configuration at time t and the reference frame i in the X metric.
This form ensures s(Xi) ' i.
– The position off the path:
z = −λ−1 log Z.
The path CVs employed in this thesis were contact map-based s-paths.
• One last tool was fundamental to this work: the reweighting technique
and its PLUMED implementation [54]. Since the well-tempered metaD
bias recovers a distribution for a variable R that is distorted with respect
to the canonical distribution, a reweighting procedure is necessary to re-
construct it. Given the original bias V(s, t) and the time-dependent distri-
bution of the new variable P(R(s), t), it can be shown that the following
reweighting relation holds at every t between the desired Boltzmann dis-
tribution associated to the unbiased potential P0(R) = e−β(U(R))/Z and
P(R(s), t) as yielded by metaD:
P0(R) = P(R, t)eβ(V(s,t)+c(t))
where c(t) = − 1
β
log
( ∫
ds e−β F(s)∫
ds e−β (F(s)+V(s,t))
)
is the time-dependent bias
offset and F(s) results from eq. (2.7). This applies both to the well-
tempered metaD CVs and a generic set of variables R extracted ex post
from the same metaD simulation (in which case the relation R(s) is
known at every time t).
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2.2 structure-based modeling
The protein folding problem, namely the fact that an elongated and disordered
polypeptide sequence univocally folds in one structure on the ms timescale
only for a small subset of all the possible polypeptide sequences, found a con-
venient description in the energy landscape theory [55]. According to it, only
those sequences that admit a spatial configuration that maximizes the number
of competing sets of favorable interactions with respect to other conformations
can fold fast and efficiently. This can be rephrased as the notion that only
mildly frustrated sequences can efficiently fold, where the term frustration
stands for the impossibility of satisfying many different sets of favorable con-
tacts at the same time. In this view, each possible sequence is characterized
by a certain degree of frustration, but protein sequences share the quality of
a funneled and relatively smoothed energy profile driving their folding pro-
cess. From an evolutionary standpoint, the folding behavior of proteins can
be thought as resulting from an amino acid sequence optimization under the
constraints of evolutionary robustness and biological efficiency [56].
From a modeling point of view, this means that there is a physical basis in
shaping the energy function (the Hamiltonian) as a funnel with the expected
folded structure, known a priori, at the energy minimum. This can be achieved
by the definition of effective interactions between native contacts, specific pairs
of atoms that are close (within a certain criterion) in the folded, or native,
structure. Assigning an energetic preferentiality to native contacts overcomes
the frustration problem, and is at the base of the development of models that
ignore non-native interactions and reward only the native ones. These are
called structure-based potentials or Go¯ models. Originally they were first pro-
posed by Nobuhiro Go¯ in 1975 [57, 58] and have been proved successful in
many cases [59, 60]. In its most common variant, the Go¯ model is a coarse-
grained representation of the residues, each represented by a bead centered at
the location of the Cα atom, and where stabilization is achieved through native
interactions only [61].
Why these potentials are efficient in reproducing protein folding from a generic
unfolded state is understandable, for the native conformation is just the global
energy minimum of the minimally frustrated, purely structure-based Hamilto-
nian. However, there is a high price to pay in accuracy with respect to classical,
all-atom empirical force fields that are parametrized on quantum chemistry
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calculations and experiments and give access to accurate sampling. So while
structure-based models proved to be powerful tools to sample the large confor-
mational changes that occur on long timescales, they need to be supplemented
with more refined calculations to investigate the atomistic detail, since the bio-
chemistry of the problems these methods aim to address dramatically depends
on local modifications of reduced subsets of residues. This quest for a balance
between efficiency and accuracy recently laid the foundation for the develop-
ment, after the first Go¯-model, of new purely structure-based refinements such
as introducing residue heterogeneity in the Cα interactions [62] and the all-
atom treatment instead of the coarse grain [63, 64, 65], all always featuring
native interactions to assure stability. Ideally, reproducing a long timescale
process while including the most possible complete detail on relevant atomic
interactions and at the same time being less computationally expensive than
empirical force fields, would be of great importance in the field of molecu-
lar simulation of biomolecular systems. Still, in all kinds of purely structure-
based models there is no consideration of the realistic dynamics of atoms, as
it can be yielded for systems of limited size by state-of-the-art classical force
fields. This compromises the predictive power of these two opposite meth-
ods and seriously limits the remarkable potential insight they could release if
properly merged together. Recently, this led to the proposal of hybrid models
that [66, 67] blend a realistic full atom potential with a Go¯-like potential biased
towards the native state structure. The model presented in this thesis joins this
last category of methods and its details will be described in the next section.
2.3 model
interaction potential The hybrid structure-based model [68] used in
this work hinges on a Hamiltonian for heavy atoms built merging the topology
yielded by a state-of-the-art force field for the bonded terms and a contact-
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based potential for non-bonded interactions. It has the following functional
form:
Uhybrid = Ubonds +Uangles +Udihedrals︸ ︷︷ ︸
bonded interactions
+UGo¯
= ∑
i,j∈ b
1
2
Kb, ij(r− r0)2 + ∑
i,j∈ b
1
2
Kϑ, ij(ϑ− ϑ0)2
+ ∑
i,j∈ b
Kϕ, ij[1− cos(nϕ+ δ)]︸ ︷︷ ︸
From classical force field
+ ∑
i<j
∈
native pairs
εSB
( r0ij
rij
)12
− 2
(
r0ij
rij
)6+ ∑
i<j
non native
pairs
(
WHS
rij
)12
︸ ︷︷ ︸
Go¯ / Structure-based
(2.10)
where the structure-based part is constituted by a sum of Lennard-Jones poten-
tials between the native pairs, each with a minimum at energy −εSB located at
the native distance r0ij, and and a hard-sphere repulsive term for all non native
pairs (for which the parameter WHS = 0.2 nm is defined to avoid unrealistic
overlaps between atoms). This is conceptually similar to other publicly avail-
able structure-based protocols [63, 69], but differs in not leading to perfectly
funneled potential energies. Rather, it includes an element of ruggedness to
the energy landscape by retaining the bonded interactions, and implement-
ing the native bias through the replacement (except for 1-4 dihedrals, that are
mantained from the original force field) of non-bonded interactions with the
Lennard-Jones potentials. Electrostatics was removed from the computation,
assuming its effect was included implicitely in the effective interactions. Con-
sequently, all charges were set to zero.
dynamics Systems were evolved under stochastic dynamics in vacuum with
the GROMACS engine [38, 39, 40, 41]. This consists in two additional friction
and noise terms in Newton’s equations of motion:
mi
d2ri
dt2
= −miξi d
2ri
dt2
+ Fi(r) + r˚i
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Figure 2: Lennard-Jones function, with εSB = −1
where ξ is the friction constant [1/ps] and r˚(t) is a noise process with 〈r˚i(t)r˚j(t+
s)〉 = 2miξikBTδ(s)δij.
choice of the contact pairs and multistate character of the
model The pairs of atoms in contact (equivalently referred to in the follow-
ing also as native pairs, native contacts, or just contacts) for the structure-based
potential were chosen according to the shadow approach [64], a measure aimed
to include screening effects, where two requirements are enforced: that the
atoms would be included within a cutoff distance of 5 Å and a cutoff angle of
35◦ (see fig. 3). This is more realistic than the traditional native pair definition
of Cα Go¯ models, which is based on a cutoff value only, as it does not allow the
number of contacts to grow indefinitely, but rather leads to saturation as the
cutoff distance increases. Also, pairs of atoms belonging to aminoacids sepa-
rated by less than three residues in the sequence were neglected. In the case of
the conformational transitions, various conformations (or native states) were
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k
Figure 3: Rationale for determining a non-screened atom pair (i,j) in the vicin-
ity of a screening atom k .
included in the topology, each through its set of native contacts. If a certain
contact was common to various native states, the least of the two distances was
chosen as the Lennard-Jones minimum in the model’s potential.
The list of contacts was first extracted after equilibration with unbiased all-
atom classical MD in explicit water for at least 5 ns at 310 K and further mini-
mization in vacuum Any effect due to the presence of water molecules, either
incidental or functional, has then been filtered out at the price of losing the
functional ones. In the version of the model that was used for the results of
the fourth chapter, such list was filtered retaining only those pairs whose aver-
age distance plus standard deviation d+ 〈d〉 along 2 ns of equilibration stayed
below the 5 Å threshold.
choice of εSB In the structure-based term, all Lennard-Jones functions have
depth −εSB at the native distance r0ij. Clearly, the behavior of the system is
strongly dependent on εSB, so its choice is critical.
If εSB is too weak, the energy landscape will be excessively rugged, the system
Native states
One-state model 
(folding and assembly)
Two-states model
(conformational changes)
U
Potential 
energy
Figure 4: Potential energy profiles for a multistate model
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will be mainly driven by bonded interactions and will just sample the local
minimum it is trapped in. Moreover, this sampling would not even be phys-
ically accurate, because of the absence of the long-range part of the classical
force field. The system would lack folding ability as well, because the essen-
tial, structure-based interactions will not be strong enough to take over the
classical part of the force field. On this side of the spectrum, then, not only
the model would approach too closely a classical, force field-driven molecu-
lar simulation but, for a comparable computational investment, a full classical
topology would demonstrate more convenient and reliable.
If, on the other hand, if εSB is too high, folding will be achieved quickly in a
mainly flattened energy landscape, but the atomistic detail of the evolution of
the system will get overshadowed by the intensity of native interactions and
the transition state ensemble would not be sampled long enough.
For our purposes, a range of εSB ∈ (3.8, 4.5) kJ/mol for the coupling parameter
was identified as appropriated to keep into the proper account these two op-
posite tendencies. To determine this range, a classical MD of 10 ns of the c-Src
kinase domain in explicit solvent at 310 K (using as force field the AMBER99SB*
modification of ff99SB ([29]) combined with AMBER99SB-ILDN force field [30])
was taken as reference for a series of short stochastic dynamics of 2 ns each, in
vacuum at 310 K, governed by the structure-based Hamiltonian having a range
of values of εSB of 2-8 kJ/mol at steps of 0.1 kJ/mol, for a total of 61 short
simulations. Comparison of the root mean square deviation of the atoms’ root
mean square fluctuations with respect to the reference for all the heavy atoms,
Cα, and sidechains’ atoms was performed to assess the model’s limits of op-
timal replication of the natural protein’s flexibility. The relative plot shows
a shallow minimum enclosed by the two extreme conditions in the (3.8, 4.5)
kJ/mol region.
21
2 Computational methods
Figure 5: Root mean square deviation with respect to the reference MD of the RMS
atoms fluctuations for different values of εSB.
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F O L D I N G
3.1 introduction
Protein folding is the process for which structure-based models were originally
proposed. Since their first steps [57], these models fostered discussion and con-
tributed to a deeper theoretical understanding of this subject with the help of
computer simulations. The existing, remarkable body of work in this field was
used to ground our model, in preparation for the treatment of conformational
transitions.
I start by describing the system under consideration, then introduce the quanti-
ties useful for the analysis and finally present the results and a few additional
considerations.
3.1.1 the folding benchmark
The SH3 domain per se attracted interest in the study of folding processes for
having its structured part mostly composed of β strands. It has become an
archetype for β sheet and two-state folding thanks to many works dedicated
to its characterization [70, 71]. Two perpendicular beta-sheets composed of, re-
spectively, three and two anti-parallel β-strands build up the basic fold of SH3
domain (see fig.8). Two loops, one hairpin, one turn and a helix 310 turn con-
nect these β-strands to shape this characteristic β-barrel. We used the structure
of human c-Src SH3, extracting it from structure 1FMK [72]. The simulated
strand amounts to 55 residues. Its experimental transition temperature is 350
K [70].
3.2 definitions
Protein folding inspired the definition of many dedicated characterizing quan-
tities and the use of already existing ones from thermodynamics. For our pur-
pose of comparing the performance of the model with known experimental
facts, we chose the following ones.
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average q For a whole protein (or a set of residues), 〈Q〉 (or 〈q〉) is defined
as the average fraction of native pairs formed in the transition state at a fixed
temperature with respect to the total number of native pairs. In our case, a
native pair is considered formed if the separation between its atoms is within
1 Å from the native distance, and should approach 1 in the folded state and 0
in the unfolded state.
The quantity 〈Q〉 is capable of discriminating between the extremes of the
transition of interest. Thus, it was used as order parameter for the heat capacity
(see next paragraph) and as free energy coordinate. As a consequence, 〈Q〉 was
also used to determine the folding (or critical) temperature Tf , defined as the
temperature at which the two free energy minima are equal, and equivalently
the probability to find the system in the native state is equal to the probability
to find it in the unfolded state.
heat capacity at constant volume The behavior of the heat capacity
in function of the temperature (I will be using CV(T), the heat capacity at
constant volume) is capable of providing insights on the folding transition of
a protein because, at the folding temperature, it presents a peak. This quantity
provided us a second facet on the folding temperature, besides the first that
was indicated by the free energy profile.
We exploit the following relation from statistical mechanics between the heat
capacity at constant volume CV(T) and the energy fluctuations
∆E =
√〈(H(Q)− 〈H(Q)〉)2〉:
CV(T) =
(∆E)2
kBT2
(3.1)
where kB is the Boltzmann constant.
cooperativity index κ2 The notion of cooperativity describes the ability
of a sequence to overcome energetic frustration in the conformational search.
It is known that the folding of helical domains is driven by local interactions,
while sheet formation and irregular patterns are rather dominated by nonlocal
interactions and thus rely on a higher degree of cooperativity for folding. Here,
to account for the transition cooperativity, we used the measure
κ2 = 2
Tpeak
∆
√
kB CV(Tpeak) (3.2)
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where ∆ =
∫ TR dT CV(T) is an integral across the transition region (adapted
from [73]). The maximum value for κ2 is 1. Thus we expect a κ2 approaching
this maximum value for β folding.
3.3 methods
I report on the analysis of a parallel tempering MD of 40 replicas in the tem-
perature range 350-370 K, with εSB = 3.8 kJ/mol. The simulation was 500 ns
long with exchanges between replicas attempted every ps.
The energy distribution corresponding to each temperature is reconstructed
from the trajectories via the multiple histogram method [74].
3.4 results
3.4.1 free energy of folding
Following our considerations on 〈Q〉, the critical temperature for SH3 with our
model is found at 357 K and a barrier of 14 kJ/mol separates the two states.
Fig.6 shows the free energy at this temperature (solid line). A remarkable
discrepancy in the population of the two basins at temperatures close to Tf is
also highlighted in the image with dashed lines.
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Figure 6: Folding free energy with respect to 〈Q〉 around the transition tem-
perature Tf = 357 K.
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3.4.2 heat capacity
The upper panel of fig.7 shows the heat capacity at constant volume as a func-
tion of T, whose peak at 357 K coincides with the transition temperature. The
fact that the transition temperature is very close to the experimental one (350 K,
[70]) strongly indicates that the model blends its two force field and structure-
based flavors in balanced proportions through εSB. The substantial consistency
of the model’s temperature to the physical temperature has primary impor-
tance here, since the force field parameters that it includes are parametrized on
the standard thermodynamic definition of temperature. This is at variance with
pure structure-based models, that do not contain classical force field contribu-
tions and are thus freed from the need of full consistency between simulation
temperature and physical temperature. In such pure structure-based models,
while the simulation temperature still drives the transition by contrasting the
force of native interactions, it by no means numerically coincides with the stan-
dard definition of temperature that compares with experiments.
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Figure 7: Heat capacity at constant volume (higher panel) and < Q > VS T
(lower panel) for various structural motifs.
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Figure 7 also shows the evolution of different < q > values with temperature.
The solid line refers to < Q > for the whole protein. We also calculated 〈q〉
as a function of T for the β-sheet composed by the three strands s4, s5 and
s6 (see fig.8) building the main part of the hydrophobic core of SH3. This
allowed to checked the degree of formation of subsets of this structure around
the transition state according to our model.
The results (fig.7, lower panel) show the following local behavior:
• The whole subset of the three β strands has 〈q〉 decaying faster to low
values than the whole protein, meaning that this group as a whole is
unstructured in the transition state;
• The event above may be driven by the disassembly of part of the three
strands. In fact, the subset of strands 5 and 6 (s5 and s6 in fig. 7 and
8; respectively, residues 42-47 and 50-55) reveals to be more stable than
the average. This hairpin-shaped motif connected by the distal loop was
confirmed experimentally as relatively well structured in the transition
state by mutagenesis studies [75].
s4s6
s5
distal loop
n-src loop
Figure 8: The SH3 domain and its characteristic three β-strands structural core.
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• Strands 4 and 5, connected by the n-src loop (s4 and s5 in fig. 7 and 8),
remained constantly below the average 〈q〉 of the whole protein indicat-
ing early unfolding. This notion found also confirmation in experimental
mutagenesis studies [75].
The cooperativity index amounted to κ2 = 0.80, indicating a high degree of
cooperativity (maximum value for κ2 is 1) of the transition.
Both with respect to the transition temperature and the evolution of structure
loss as denaturing condition strengthen, the model is consistent with experi-
mental indications [70, 75]. We conclude that the description of the transition
state provided by the model with respect to β folding represents a positive
proof on the model’s performance.
other validations A discussion of the previous results and additional
characterizations (including Φ values calculation1) can be found at ref.[68].
In this paper, a protocol validation similar to the one described for SH3 is re-
ported for the villin headpiece HP35 to create an analogous benchmark for
α folding. The HP35 subdomain is composed of 35 residues structured in
three helices. It is the extreme part of a compact f-actin binding domain lo-
cated in the C-terminal part of protein villin. It is highly thermostable and
has been described as the smallest monomeric sequence characterized that
folds autonomously into a unique and thermostable structure, that is consti-
tuted of only naturally occurring amino acids and whose folding process does
not depend on disulfide bonds or ligand binding [76]. Like SH3, its folding
has been studied extensively on the computational and experimental front
[76, 77, 78, 79].
I calculated the cooperativity index for HP35 for our model and, in agreement
with the expectation of a lower value for α folding, it amounts to κ2 = 0.53,
which helps to confirm the model’s physical reliability in combination with
the κ2 = 0.80 value for SH3 and β folding.
1 To measure the stability of a single residue in the transition, Φ values are commonly used as
an indicator. In general terms, Φ values have a simple interpretation: a value approaching zero
stands for a low occurrence of the residue contacts in the transition state, whereas a value close
to 1 stands for a residue that participates to a highly structured strand in the transition state. Φ
values can be measured both experimentally and computationally.
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Thanks to the mentioned indications, we concluded the tuning phase for our
model. We then proceeded to targeting it towards conformational transitions
in proteins.
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C O N F O R M AT I O N A L T R A N S I T I O N S I N C - A B L
4.1 remarks on modeling folding and conformational
transitions
Now that we have described the validation phase of the model on folding, it is
worth to consider the leap we are making by transferring a mainly structure-
based model to the description of conformational rearrangements. Awareness
on the qualitative differences between these two transitions is necessary, as they
are two close but distinct physical phenomena.
Folding is a global transition with the traits of a finite system phase transition (a
peak in the derivative of the free energy with respect to an order parameter, in
this case 〈Q〉, the average fraction of native contacts formed). On the contrary,
the large-scale conformational transition is local since it involves a minority of
the components of the system, and this fixes specific constraints. While dur-
ing unfolding the system is driven out of a single minimum, a conformational
transition corresponds to a controlled transition between two local minima via
a transition state. Consistently, the unfolded extreme of the folding transition
is high and highly degenerate in energy, while for local conformational tran-
sitions the two extremes are structurally well defined and is the region of the
transition state to be the highest in free energy and entropy. Consequently,
from the standpoint of modeling a temperature-induced transition (through
the intensity of the native contacts εSB), in order to avoid temperature-induced
unfolding of the whole protein, contacts that ensure fold stability may require
a different treatment from those involved in the targeted local conformational
transition.
Having said that, two-state folding has been investigated extensively on
the experimental and theoretical front and provides a natural and convenient
framework to start from.
***
The present chapter describes the first application of our hybrid model to a
multidomain protein, a case of great interest in cancer research. I start by
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describing the protein our method was applied to, c-Abl, together with the
multifaceted challenges this protein presents to the scientific community and
relatively to which, we submit, our model can provide insight. Next, results are
presented with the discussion about how they contribute to the debate c-Abl
currently fuels.
4.2 c-abl
The term c-Abl protein indicates the cytoplasmic and nuclear nonreceptor ty-
rosine kinase encoded by c-abl proto-oncogene 1 (ABL1).
c-Abl kinase is expressed ubiquitously in mammals [5]. One paralogue, Arg
(abl related gene, ABL2), has been found for c-Abl and with it constitutes the
ABL subfamily.
Human c-Abl kinase is 1182 residues long. It is expressed in two N-terminally
differing isoforms: 1b, with the N-terminal cap bound to a myristoyl fatty acid
(Myr), and 1a, nineteen residues shorter and not reported to be myristoylated
[80]. Next to this spliced segment, the two polypeptide chains fold identically
in one Src homology 3 (SH3), one SH2 module and a tyrosine kinase domain.
This linear modular arrangement of SH3, SH2 and catalytic domain is common
to c-Abl and the closely related c-Src tyrosine kinase. A long C-terminal do-
main, named last exon region, of about 90 kDa and unique of c-Abl follows. It
contains several binding and recognition sites, namely three proline-rich bind-
ing sites (PXXP) for adaptor proteins, three nuclear-localization signals, three
tandemly repeated DNA-binding domains, G- and F-actin binding domains
and finally a nuclear-export signal (NES)[5].
The kinase domain of c-Abl catalyzes phosphorylation of a tyrosine in peptide
c-Abl
c-Src
Last exon region
Kinase domainLinkerSH2SH3
N-Cap
isoform 1a
N-Cap 
Isoform 1b
Myristoyl 
group
Tyr/pTyr 412
Tyr/pTyr 416 Tyr/pTyr 527
Kinase domainLinkerSH2SH3Unique region C-terminal tail
Homologous regions
Figure 9: Modular organization of c-Abl and c-Src.
33
4 Conformational transitions in c-Abl
substrates. While c-Abl belongs to the ABL subfamily, and at a higher level
to the group of nonreceptor tyrosine kinases, the fold of its kinase domain is
a shared feature of the whole kinase superfamily, estimated to include 518 ki-
nases [11]. It consists of a strand of about 300 residues organized in two lobes
connected by a hinge region and defining a deep cleft where ATP binds. The
N-terminal lobe is smaller and composed of beta sheets, except for a conserved
critical helix, called αC-helix. The C-terminal lobe is mainly helical.
The catalytic domain performs the biochemical function associated to any ki-
nase protein: the phosphorylation of protein substrates, namely the transfer of
the γ phosphate of ATP to the hydroxyl groups of a serine, threonine or tyro-
sine residue. This is realized by a catalytic domain that exhibits the following
defining traits of an active conformation.
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4.2.1 general features of active and inactive protein kinase
domains
activation loop A glaring, common indicator of an activated kinase do-
main is the position of a flexible strand of about 20-30 residues called activation
loop and located between the two lobes. This region can severely contribute
to inactivation by hindering substrate binding. Consistently, in an activated
state it is removed from the substrate binding region (like in fig.10) and, in
c-Abl, stabilized in this extended conformation by phosphorylation of Tyr 412
(human c-Abl 1b numeration1).
1 The numeration we will always refer to in the following for c-Abl, unless otherwise stated.
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Figure 10: Kinase domain with the open activation loop in green (the compar-
ison with opposite conformations can be better appreciated when I
discuss specific conformations at page 47). Key residues of the ac-
tive site are shown in licorice representation. See fig.11 for a higher
detail on these residues.
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active site and αc helix Regarding the active site, two key ionic bonds
between highly conserved residue pairs have been recognized as shared among
the whole kinase family [12]. One involves Asp 382, which additionally inter-
acts with ATP, and Asn 387, needed for the binding of one Mg cation.
The state of the second salt bridge is characteristic of two main inactive confor-
mations of the kinase domain and involves Lys 290 from sheet β3 in the N-lobe
and Glu 305 from the αC helix. These two classes of inactive conformations
are commonly referred to as Src-like and Abl-like inactive conformation. They
differ primarily in: 1) the orientation of the sidechain of residue Glu 305 and
2) the orientation of residue Asp 400 from the DFG motif, first of a highly con-
served triad (Asp 400 - Phe 401 - Gly 402) located at the base of the activation
loop and at the core of the active site (discussed in the next paragraph).
Residue Glu 305 is conserved both in Src family kinases (SFKs) and c-Abl. In
the active conformations, it establishes an ion pair with Lys 290 that forces it
to point towards the active site and the longitudinal axis of the domain. In the
main inactive conformation of SFKs this pair is disrupted: the Glu is rotated
and steadily surface-exposed by another ion pair with the likely orientated Arg
405 from the activation loop, defining one feature of a Src-like inactive confor-
mation. In c-Abl and other kinases this breakage is not observed in most of
the inactivated structures, a fact considered distinctive of an Abl-like inactive
structure.
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Lys 290
Glu 305
DFG motif
Tyr 412
Asn 387
Asp 382
Arg 405
αC helix
Figure 11: Detail on the active site.
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dfg motif A possible inactivating transition involves primarily the DFG mo-
tif, the triad (Asp 400 - Phe 401 - Gly 402), located in the active site. Asp 400
sidechain points towards the active site in the active conformation and is func-
tional to Mg2+ coordination. The Asp sidechain can significantly move away
from the coordination site, a fact that results in Asp 400 and Phe 401 swapping
positions for steric and stereometric reasons, and that can be seen as an overall
crankshaft-like rotation of the whole DFG segment (see fig. 12). The result of
this movement is referred to as the DFG flipped, Asp out conformation and
is sufficient for inactivation. Briefly, then, for what concerns these two critical
sidechains, an active kinase domain has the αC helix Glu pointing inwards and
the DFG Asp pointing towards the active site. When inactivated, the Abl-like
kinase retains Glu inward-directed and has the DFG Asp pointing out, and the
Src-like one features Glu outwards and retains the DFG Asp in (see table 1).
This conformational discrimination is paramount also when it comes to the de-
velopment of selective ATP-competitive inhibitors. In particular, the DFG-out
conformation is required for high affinity imatinib binding and provides the
molecular basis for the restricted selectivity of the drug, paving the way for the
groundbreaking clinical success of this inhibitor in Ph+ diseases and freezes
the kinase domain in an inactive state.
Time told, though, that the association of the different conformations with in-
active Src and Abl was less rigid than the expected and a Src-like inactive
conformation was found for inhibitor-bound Abl [81] and vice versa [82].
Levinson et al. managed to capture in 2006 c-Abl accessing a Src-like inactive
DFG in DFG out
Figure 12: The crankshaft-like character of the DFG transition. See also page
47 for the orientation of Asp 400 in two experimental structures.
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DFG→ in out
αC Glu ↓
in active Abl-like
inactive
out + Glu 305 - Arg 405 salt bridge intermediate
→ Src-like inactive
Table 1: Possible combinations of critical residues’ arrangement and their rela-
tionship with activation states. Adapted from [81].
conformation (αC Glu out and DFG Asp in) in the presence of an ATP analog
peptide conjugate [81]. Here, the DFG Asp 400 points towards the kinase axis
and forms the mentioned critical ion pair with Lys 290. A solvent-exposed salt
bridge between the αC Glu 305 and Arg 405 from the activation loop is also
highlighted. This Src-like structure has been interpreted as a possible interme-
diate conformation towards the DFG flipped conformation and a number of
correlated observations is provided on the possible flipping pathway. A spe-
cial role for residue Arg 405 in the DFG flip is suggested. This residue forms
part of a peculiar helix 310 turn and additionally interacts with two residues
from the catalytic loop, and because of this it was found to be properly ori-
ented to catch and stabilize Asp 400 while it flips downwards and outwards
from an in conformation. This is consistent with an intermediate minimum in
c-Abl reported in [83]. Also, the αC Glu transition finds a possible electrostatic
stabilizer in Arg 381 all the way to the salt bridge with Arg 405.
Complete DFG flip was reproduced in simulations of the Abl kinase domain
[84, 83, 85].
In [84], pH was proposed as a factor affecting the kinetics of flip through Asp
protonation and the in→ out flip was detected 3 times in unbiased MD simula-
tions in slightly diversified surroundings but always with Asp 400 protonated
at 300 K and 1 bar. In equivalent conditions, the flip of unprotonated Asp did
not occur. These observed flips were consistent with the counterclockwise pro-
tonated Asp-Phe passage proposed in [81]. Simultaneous to the most sterically
hindered step with Phe pointing upwards, maximal displacement of the αC
helix was observed.
For what concerns free energy calculations, it is necessary to sample the DFG
transition up to convergence to equilibrium to estimate the free energy dif-
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ference between the two DFG states. Once this level of sampling has been
attained, the following formula is used:
∆F = F1 − F2 = − 1
β
ln
(
N1
N2
)
(4.1)
where N is the number of times the given state is visited in the equilibrium
ensemble. Unbiased simulations do not provide a sufficient sampling of the
states, even on purpose made supercomputers, while an approach based on
enhanced sampling was able to converge the free energy landscape associated
with this transition [83]. This was done via parallel tempering metadynamics
[52] on c-Abl and c-Src kinase domains, obtaining respectively:
• ∆Fin→out = Fout − Fin = 4.0 ± 0.5 kcal/mol, with an intermediate min-
imum of 1 kcal/mol under the DFG-out free energy value, consistent
with the indications of [81];
• ∆Fin→out = 6.0± 0.5 kcal/mol and no intermediate minimum was found.
In [85], the comparable potential of mean force relative, obtained from umbrella
sampling MD at 300 K and 1 atm, was measured in ∆Fin→out = 1.4 kcal/mol
for c-Abl and 5.4 kcal/mol for c-Src.
A less computationally expensive scheme has been pursued in [86] and pointed
out a conformational advantage of the DFG-in conformation for c-Src of 4.7
kcal/mol, and a similar but less definitive indication for phosphorylated c-Abl
of 3.4 kcal/mol.
In conclusion, all computational indications, despite the usage of different
methods, qualitatively agree in indicating the DFG Asp-in conformation as
the most energetically favourable for c-Abl.
hinge motion The catalytic activity also depends crucially on the collective,
relative movement and orientation of the two lobes. They both contain the
structural apparatus (like, respectively, the αC helix and the activation loop)
that, with the deriving atomic critical interactions, control the catalytic cycle.
Additionally, they must also open and close to allow ATP binding and ADP
release, because the catalytic cleft is located between them. The fluctuations of
the lobes around their juncture are thus part of the interplay of correlated inter-
actions that compose the catalytic cycle of a kinase: they both reflect and affect
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other relevant conformational transitions for protein function. This collective
displacement has been described as the “breathing movement of the kinase
domain” and will also be investigated in the following.
4.2.2 a model for c-abl regulation
The concept that c-Abl admits an autoinhibiting modular arrangement has
found increasing support [87, 88] at the beginning of the last decade over the
idea that a cellular substrate was the cause of its inhibition [5].
An important step towards this conclusion was published in 2002, when Pluk
et al. showed for c-Abl 1b [87] that the whole segment C-terminal to the kinase
catalytic domain (beyond residue Glu 531) is not required for the regulation of
kinase activity. Instead, they showed the minimal segment required in Abl 1b
to see activity suppressed includes segments 1-531, with a critical role of the
strand 1-81. This was proved on c-Abl 1b, and the isoform 1a was included in
the model on the basis of evidences of an analogous behavior. This implies that
this strand contains all the key factors for c-Abl full catalytic control. We know
this includes one C-terminal unstructured tail, one SH3 domain, one SH2 do-
main, a linker to the kinase domain and the kinase domain itself.
The SH2-kinase domain motif is known to specifically bind phosphotyrosines
(pTyr) [89, 90] and is highly conserved in all cytoplasmic tyrosine kinases [91].
In this scenario SH3 may respond to more specific needs for c-Abl regulation
rather than SH2. SH2 comprises about one hundred residues folding in a cen-
tral anti-parallel β-sheet core surrounded by two α-helices [92], and pTyr binds
to a positively charged pocket on one side of the β-sheets. Like the kinase fold,
also the SH2 fold is more conserved than its sequence, a fact that realizes not
only the primary requirement of specifically binding pTyr residues, but also
sequence specificity, that is the capacity of selecting the binding partners by
their ability to bind the tyrosine-surrounding residues (this ability has been
reported on sets of residues that can span, assuming pTyr at position 0, the
range (-6,+6), but most often (-2, +4) [93]).
The abundance of crystal structures published in the last decade contributed
increasing evidences to support a model for c-Abl autoinhibition originally in-
troduced in [94, 95]. We will now describe this model with the aid of a few
crystal structures that also represented an important experimental underpin-
ning for the original work illustrated in this thesis. Especially important for
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this description are two structures deriving from the same asymmetric unit
that contains two molecules at 3.4 Å resolution (structure B of [88], 1OPL) in
two dramatically different states of assembly (similar to those shown in fig.13).
In the first molecule of 1OPL, a major portion (residues 81-531) of the strand ca-
pable of autoinhibition (1-531) of c-Abl is revealed. Its arrangement consists in
a compact organization of the three modules, with the SH3 and SH2 domains
docked distally to the active site and respectively adjacent to its N- and C-lobe.
The linker connecting SH2 and the N-lobe runs throughout the whole length
of the docking site, mediating SH3 anchoring via intramolecular interactions
with the N-lobe, while allowing direct interaction between SH2 and the C-lobe.
In this modality, as well as in any other else ever observed in this protein,
the modules never get to occupy the region involved in substrate binding and
activation loop movement, but rather the opposite side of the kinase domain,
often referred to as the backside region. Such disposition rigidifies the hinge
motion and this effect echoes on other relevant conformational transitions. In
fact, when the regulatory apparatus is docked parallel to the kinase domain in
the autoinhibited conformation and this motion is constricted, so are those of
the activation loop and of the DFG motif because of their location between the
two lobes.
The interaction between SH3 and linker in the assembled arrangement is also a
contributing factor in the inactivation process. Its robustness relies on the con-
served property of SH3 of specifically binding to polyproline motifs with the
consensus PXXP and forming a left-handed type II helix [96]. In consideration
of this notion, two prolines in contact with SH3 stand out in the linker’s three
dimensional arrangement. In fact, their mutation was an important part of the
engineering process of a constitutively activated construct that led to one of the
rare structural traces of activated c-Abl [97]. The strength of c-Abl linker/SH3
interaction was shown to conserved even in absence of the kinase domain [98].
A structure at higher resolution that shows high similarity to the mentioned
assembled structure is presented at 1.8 Å resolution in the same paper for the
murine c-Abl 46-534 segment2, to which an inhibitor and myristic acid were
added, respectively, during purification and crystallization. It was the first
time that a similar multidomain structural arrangement was revealed in c-Abl,
while an analogous, in spite not identical one, had already been described for c-
2 Murine c-Abl differs from human protein in residue 336, where is respectively a Ser and an Asn.
43
4 Conformational transitions in c-Abl
Src [99] and Hck [100]. The intensity of the direct interaction between the SH2
and C-lobe interface has been experimentally proven in hydrogen exchange
mass spectrometry (HX MS), which revealed this interface remained protected
by deuterium exchange for longer than any other region of the construct. Also,
myristoyl group removal caused disruption of this interface and the deuterium
exchange levels show consistency with the establishment of the top SH2-N-lobe
interface [101].
These arguments all support, hence, the need of a more clear view on the
machinery of c-Abl and of the closely related c-Src, that shares much of the
auxiliary setup. In particular, understanding in which way the same adaptor
domains may influence dynamics and contribute to explain opposite binding
affinities to inhibitors is a challenging question of clinical relevance. The re-
markable dimension of this system, about 500 residues and 60 kDa, puts it at
the limit of current capabilities both on the computational front and on the
structure-biological one. This fact motivates the relative rarity of indications
regarding this system with respect to those regarding the isolated kinase do-
mains.
The second 1OPL molecule depicts the stretch 140-238 and 252-518 of human
c-Abl 1b at 3.4 Å resolution (second molecule of structure B, 1OPL [88]). It
represents a structure of c-Abl in which only SH2 and the kinase domain are
resolved in a peculiar arrangement. This arrangement, defined unusual by
the authors in 2003, represents SH2 located on the top of an activated kinase
domain with the open activation loop. The protein was found intact and com-
pletely myristoylated by mass spectrometric analysis.
Comparison of these opposite arrangements also reveals a conformational tran-
sition in the terminal helical region of the C-lobe, helix αI. In the context of the
myristoyl-free kinase domain alone, this helix has sometimes been revealed in
a distinguishable array of about six turns [81, 102]. In the assembled organiza-
tion and in the myristoylated kinase domain alone, the number of helical turns
breaks down to 4 (αI) + 3 turns (αI’): the helix is bent of about 90◦ towards the
N-lobe, where it engages in interactions through Ile 521, Val 525 and Leu 529
with the myristoyl group. Such an αI-I’ arrangement is the only one compatible
with SH2 docked at the base of the C-lobe. In the mentioned activated layout
with SH2 anchored on the top interface, the αI helix conformation is compati-
ble with the extended arrangement, but is one of the many structures whose αI
helix is not fully resolved. The findings of [88] support a view for the αI helix
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Kinase domainLinkerSH2SH3
Tyr/pTyr 412
Autoinhibited Activated (1OPL B)
Figure 13: Comparison of c-Abl in the autoinhibited and activated configura-
tions.
bending as a well-defined transition induced by myristate binding, intrinsical
of the kinase domain and precursory of SH2 binding, rather than triggered by
it.
It is interesting to note here that, in c-Src, this C-terminal helix is replaced
by a tail whose phosphorylation induces SH2 binding on the lower lobe. More-
over, the oncogene product v-Src lacks the C-terminal tail but, unlike c-Abl,
shows unregulated catalytic activity. This is indicative of the dependence of
c-Abl on a robust autoinhibitory alternative and of how essential the phospho-
rylated tail is to regulation in c-Src.
After the findings described in [88], the study of the modules’ extended layout
was further pursued in search of a possible functional value via small angle X-
ray scattering (SAXS) [97]. The resolved open loop made 1OPL B a candidate
for a possible hallmark arrangement of the activated state. To test this hypoth-
esis, a mutated form was engineered so to silence those segments involved in
known inactivating interactions: starting at SH3, the protein had the autoin-
hibitory potential of its N-cap (residues 1-82) and myristoylation site removed,
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and two SH3 binding prolines from the SH2-kinase linker were mutated in glu-
tamic acids so to disrupt the linker-mediated packing of SH3 (P242E, P249E) to
the N-lobe, typical of the autoinhibited form. Kinase assays confirmed an activ-
ity 14 times higher in this construct than in the wild type [97, 103]. The kinase
domain and SH2 arrangement, as represented by the SAXS shape reconstruc-
tion [97], shows high consistency with the putatively active crystal structure.
The novel top interface covers 1100 Å2 and, on the side of SH2, it involves: the
C-terminal half of helix αA, strand βG, and three loops. The N-lobe surface
engages at the interface via strand β1, the loops between strand β3 and helix
αC, and strands β4 and β5. The core interaction involves Ile 164 of the SH2
domain, which is buried at the interface and interacts with Thr 291 and Tyr 331
of the kinase domain.
The role of Ile 164 has then been further investigated by mutagenesis. Targeted
mutation in a glutamate resulted in drastic reduction of kinase activity [93]
that mechanistically illuminates the critical ability of Ile 164 of maintaining the
SH2 - N-lobe interface suitably arranged for catalysis. This fact also indicates a
twofold regulatory character of this domain, whose two distinct interfaces act
by respectively preventing and promoting kinase activity, an effect for which
the presence of SH2 has been found necessary and sufficient [93]. The SAXS
shape reconstruction for the construct SH3-SH2-kinase domain also advanced
knowledge in relation to two elements that were previously unresolved: SH3
matched with a density region on top of SH2 and a second density region ad-
jacent to the N-lobe and SH2 is compatible with the linker’s volume.
The work of [97] also presents 2FO0, an assembled X-ray structure of human
c-Abl at 2.27 Å resolution and entailing residues 1-531 (with residues 15-56
deleted), that has been a fundamental reference for the work described here.
We described a scenario where the SH3 and SH2 domains and their atomic
contacts with the interfaces of the catalytic domain are causally linked to the
activation process of the two proteins. The details of the role of these domains
in regulation and the elucidation of the exact differences between c-Abl and
c-Src is a subject of active research. It is clear, in general, that the design of a
healthy protein encodes a precise balance of populations in its complete three
dimensional structure. The case of c-Abl, and in a certain measure also of c-
Src, is one of a strong asymmetry towards a basin of tightly down-regulated
conformations.
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To investigate this, we devised a computational scheme capable of reproducing
in silico several large-scale conformational transitions in one single trajectory
and applied it to the construct of SH3 + SH2 + kinase domain of c-Abl, whose
dysregulation can have oncogenic effects and is strongly related to the auxiliary
domains.
experiment design “What is the energetic effect of the presence of the two
regulatory domains on the transitions of the kinase domain?” This is the sort
of question that our model is the optimal tool to address, rather than recov-
ering an absolute energetic information on a specific system. Classical MD
simulations are still irreplaceable for this latter task.
In pursue of an answer to this question, a comparative scheme has been es-
tablished. We designed a multistate topology tailored on the c-Abl transitions
described above. Then, with this topology, we simulated three constructs of
increasing size: one including the kinase domain only, a second composed by
the kinase domain and the SH2 domain, and a third built as the kinase domain
+ SH2 + SH3 domains. The same free energy profiles were calculated for the
three constructs with the final goal of comparing them and isolating the role on
the targeted transitions of the auxiliary domains and the correlation, possibly
allosteric, of distant regions in or outside the kinase domain.
4.3 methods
4.3.1 structure-based topology
pdb structures chosen A requirement to include a transition in the topol-
ogy was that its extremes were experimentally determined and deposited in the
PDB data bank.
The pdb structures and the transitions encoded in the Hamiltonian as native
states after contact extraction and merging (see below the paragraph “Building
the multistate topology”) are shown in the following images and described in
their most relevant characteristics.
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Activated, open loop
pdb 2FO0
Inhibited, closed loop 
pdb 1OPJ
Figure 14: Transition 1: the activation loop opening. The loop is open in active
kinases (representative pdb: 2FO0), closed in inactive (representative
pdb: 1OPJ). Here the conformations are shown from two slightly
different angles.
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DFG (Asp 400) in
pdb 2G1T
DFG (Asp 400) out
pdb 2FO0 
Figure 15: Transition 2: the DFG flip. Asp 400 out in inactive c-Abl (represen-
tative pdb: 2FO0), in in the active kinase (representative pdb: 2G1T).
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pdb 1OPL (II molecule) 
(SH2 at N-lobe, active)
pdb 2FO0 
(SH2 at C-lobe,
inactive)
Figure 16: Transition 3: SH2 position. In the autoinhibited 2FO0 structure,
SH2 is docked to the C-lobe. In a fully active conformation (1OPL,
second molecule, phosphorylated at Tyr 412), SH2 has been revealed
adjacent to the N-lobe.
Particular care was given to this structure before inclusion in the
potential energy function. It derived from an equilibration of 1OPL
for 210 ns in explicit water performed in the research group, which
ensured the removal of possible crystallographic artifacts and the
inclusion of an accurate local energy minimum in the topology. Fur-
ther equilibration after the addition of the missing linker and other
automated structure optimizations before contacts’ merging was per-
formed for full consistency with the experiment design. The relative
native contacts account then for an active state with respect to the
activation loop (phosphorylated) and the SH2 arrangement, thus
broadening the spectrum of our topology and analysis from com-
plete autoinhibition to full activation. The atomic contacts’ num-
bering of this structure was mapped to the one of the simulated
unphosphorylated structure before merging the contact lists.
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ARG 405
LYS 290
αC GLU 305
pdb 2G1T (src-like inactive)
pdb 2FO0 (abl-like inactive)
out
in
Figure 17: Transition 4: αC-Glu orientation. Glu 305 in in active kinases (rep-
resentative pdb: 2FO0), out in inactive (representative pdb: 2G1T).
More in general the structure 2G1T shows the feature of a Src-like
inactive conformation, with disruption of the Lys 290 - Glu 305 ion
pair in the active site and establishment of the solvent-exposed pair
Glu 305 (αC) - Arg 405 (activation loop).
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pdb 2QOH (extended αI helix) 
pdb 2FO0 (bent αI helix)
pdb 2QOH (extended αI helix) 
pdb 2FO0 (bent αI helix)
pdb 2FO0 
(SH2 at C-lobe)
pdb 2QOH 
(extended αI helix, active, kinase domain only)
pdb 1OPL (II molecule) 
(unresolved αI helix, active, SH2 at N-lobe)
pdb 2FO0 (bent αI helix, inactive, SH2 at C-lobe)
Figure 18: Transition 5: αI helix bending. The bending of the αI helix is asso-
ciated to myristate binding. The active structure 2QOH exhibits the
extended conformation. In 2FO0 (inactive) this helix is bent due to
the presence of the myristate. Superposition with 2QOH shows that
the relative SH2 location is not compatible with the extended layout.
Additionally, we can observe that, although in the fully active 1OPL
this helix is not fully resolved, its shape is compatible with the active
2QOH, rather than with the bent helix from 2FO0 (inactive).
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contact pairs extraction The chosen structures were downloaded from
the Protein Data Bank and validated with MolProbity [104]. Then, maximal se-
quence consistency was enforced on them: eventual point mutations (none of
which of clinical relevance, but rather declared either as engineered mutations
or due to expression from a species different from Homo Sapiens) were re-
vealed and adjusted towards the human c-Abl sequence. Each structure was
then equilibrated in explicit water (TIP 3-point model) for at least 5 ns at 310
K with AMBER99SB-ILDN* force field [105, 106, 33, 107]. Two structures con-
tained a phosphorylated residue (2FO0 a serine, located in a segment not in-
cluded in this discussion, while 1OPL contained a tyrosine): I integrated the
required parameters for these residues in the force field in use, deriving them
from [108]. After equilibration, the structures were minimized in vacuum. At
this point, a first list of pairs in contact was extracted according to the shadow
approach explained at page 19, with cutoffs of 5 Å and 35◦, and a threshold
of at least three residues of separation in the sequence. Spurious contacts due
to transient fluctuations in these lists were filtered out by retaining only those
contact pairs for which the quantity d + 〈d〉 < 5 Å, where d is their average
separation distance and 〈d〉 its standard deviation during the last 2 ns of equi-
libration. Many public computational tools helped to perform this process:
VMD [109], Pymol [110], SWISS-MODEL and Swiss-PdbViewer [111]. Table 2
contains the specifics of the five simulated experimental structures chosen in
this phase.
building the multistate topology The structure-based part of the topol-
ogy is implemented by a Lennard-Jones interaction for each native interaction.
The list of the native interaction results from merging the five lists of native
contacts. Table 3 focuses on the three target structures and on the ultimate list
of native contacts used on each system. The LJ minimum is set to 4.5 kJ/mol
per native contact, except for 328 contacts of the activation loop deriving from
non-closed conformations, which were rescaled to 2.25 kJ/mol because escape
from this conformation resulted particularly difficult for the systems. This mea-
sure follows from the considerations at §4.1 and, given the comparative nature
of the study, its impact is considered acceptable. The distance of the LJ mini-
mum for each pair is the average distance calculated on 2 ns of equilibration in
explicit water. When one pair pertained to more than one native structure, the
shortest distance was chosen for the Lennard-Jones function minimum. The
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Structure Simulated Number of atoms Number of native
(pdb code) strand (including H) pairs extracted
1 (2FO0) 65-530 7379 2752
(466 residues,
SH3, SH2, linker, kd)
2 (1OPJ) 248-529 4605 1747
(282 res., kd)
3 (1OPL) 140-237, 251-521 5900 2298
(368 res.,
SH2 and kd)
4 (2QOH) 251-530 4509 1733
(278 res., kd)
5 (2G1T) 251-526 4446 1721
(276 res., kd)
Table 2: Extraction of the native pairs. The table shows quantitative details
regarding the treatment of the five experimental structures underpin-
ning the multistate topology. Under the total number of residues, the
names of the domains entailed by each strand are reported.
Structure Simulated Number of atoms Number of native
strand (heavy atoms) pairs included
in the topology
kinase domain 260-530 2193 3427
(271 res.)
kd + SH2 140-530 3158 4585
(391 res.)
kd + SH2 + SH3 81-530 3620 4969
(450 res.)
Table 3: Quantitative details on the structures simulated with the multistate
topology.
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Calculation Simulation time Average replica
(? : approximated) acceptance rate
kinase domain 1 µs 11.6 %
kd + SH2 772 ns* 8.1 %
kd + SH2 + SH3 860 ns* 6.7 %
Table 4: State of advancement and acceptance rates PTmetaD calculations.
classical part of the topology was built with AMBER99SB-ILDN* force field.
According to one of the versions of the model developed in the research group,
the parameters that refer to the dihedral angles of the backbone normally re-
ferred to as Φ1 (N1 − C1α − C1 − N2) and Ψ1 (C1 − N2 − C2α − N2 are not from
the force field but are fitted parameters that comply with the notorious Ra-
machandran plot [112] for angles [Φ1,Ψ1], where the indexes 1 and 2 indicate
two adjacent amino acids.
simulation runs We ran a parallel tempering metadynamics (PTmetaD
[52]) on six temperatures (range: 300-350 K, with a stride of 10 K) on each
of the three systems evolving under the action of a stochastic dynamics, with
friction coefficient proportional to the particle mass. Simulations were realized
with GROMACS 4.5.5 and PLUMED 1.3, with replica exchanges attempted
every ps. Table 4 compares the specifics of the three calculations with a focus
on the replica exchange performance.
4.3.2 metadynamics setup
general parameters Gaussian hills of height 2.0 kJ/mol for the kd only
and 5.0 kJ/mol for the bulkier systems were deposited every 4 ps. The well-
tempered bias factor was 5.0.
collective variables The collective variables are defined as:
CV1) S-path on 3 frames for the aloop transition. The references for the frames,
calculated on 474 atom pairs from backbone and sidechains directly en-
gaged in the transition, were: frame 1) 2FO0 (open loop); frame 2) 2G1T
(semi-closed); frame 3) 1OPJ (closed loop). The gaussian width on this
dimension was 0.03 units.
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CV2) S-path on 2 frames for the DFG transition on 108 atom pairs. The refer-
ences for the frames were: frame 1) 2FO0 (DFG Asp in); frame 2) 1OPJ
(DFG Asp out). The gaussian width was 0.02 units.
CV3) Distance between the centers of mass of the groups of atoms at the in-
terface between SH2 (27 atoms) and the C-lobe of the kinase domain (36
atoms) in the inactive conformation. The gaussian width was 0.12 nm.
CV4) Same distance as above, but for the active conformation: distance be-
tween the centers of mass of 18 atoms at SH2 interface and at the N-lobe
of the kinase domain (22 atoms). The gaussian width was 0.12 nm.
a posteriori variable extraction and reweight Given the quantity
of conformational information contained in each simulation, the analysis was
deepened with the extraction of other relevant quantities for the description
of processes of interest. After extraction from the biased metaD simulation,
the associated canonical distribution was reconstructed as described in [54]
through its implementation from the PLUMED package. The extracted and
reweighted observables are:
• Reweighted distance 1: Ile 312 CG1 - Asp 400 CG. We found that the sec-
ond CV, the s-path of two frames for the DFG transition, was efficient in
coaxing the DFG flip but not as capable of distinguishing between the
two extremes as a free energy profile coordinate. This motivated the ex-
traction of a more linear quantity: the distance between Ile 312 CG1 in
the αC helix and Asp 400 CG in the DFG motif (short when DFG Asp is
pointing outwards, long when DFG is pointing inwards.).
• Reweighted distance 2: Lys 290 NZ - Glu 305 CD. The ion pair between Lys
290 NZ and Glu 305 CD in the active site is critical for activity, as said
at §4.2.1. When the bond is formed, the kinase may be active or Src-like
inactive; when it’s not, the conformation is compatible with the Abl-like
inactive.
• Reweighted distance 3: Glu 305 CD - Arg 405 CZ. This quantity accounts
for the formation of the external salt bridge that engages the turning
glutamic acid from the αC helix in the Src-like inactive conformation. It
is minimal in such condition, and higher in any other one. See page 39
and figure 17.
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• Reweighted distance 4: Val 299 CA - Tyr 432 CA. To measure the hinge
motion (see page 41) by means of a distance, the choice fell on two amino
acids that do not participate to local transitions and stay embedded in
the lobe they belong to. These amino acids are Val 299 CA for the N-lobe
and Tyr 432 CA for the C-lobe.
Table 5 contains the values of these observables calculated for the five native
structures for numerical comparisons. The same values are also recalled in the
free energy plots. Useful information to read the plots are summarized in table
6.
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Structure CV1 CV2 CV3 CV4
(pdb code) [a.u. (∼ frame index)] [a.u. (∼ f. i.)] [Å] [Å]
1 (2FO0) 1.095 1.006 2.6 47.8
2 (1OPJ) 2.902 1.994 / /
3 (1OPL) 1.176 1.184 49.5 3.6
4 (2QOH) 1.374 1.280 / /
5 (2G1T) 2.004 1.202 / /
reweighted reweighted reweighted reweighted
distance 1 distance 2 distance 3 distance 4
[Å] [Å] [Å] [Å]
6.1 3.2 12.0 32.8
10.3 3.7 9.8 29.1
11.0 3.2 12.6 29.3
12.4 3.7 14.0 28.5
12.0 15.6 4.4 29.2
Table 5: Values of the direct and extracted CVs associated to the five native
structures contributing to the structure-based topology.
Name Description Protein region Trend
(min→ max value)
CV1 s-path on aloop Activation loop open→ closed
(3 frames)
CV2 s-path on DFG DFG motif out→ in
(2 frames)
CV3 distance from SH2 SH2 and SH3 inactive→ active
lower interface position
CV4 distance from SH2 „ active→ inactive
higher interface
reweighted distance DFG out→ in
distance 1 Ile 312 CG1
Asp 400 CG
reweighted distance active site active→
distance 2 Lys 290 NZ inactive (Abl-like)
Glu 305 CD
reweighted distance external salt bridge inactive (Src-like)→
distance 3 Glu 305 CD Src-like inactive any other state
Arg 405 CZ
reweighted distance hinge motion
distance 4 Val299 CA
Tyr432 CA
Table 6: Key features of the direct and extracted CVs.
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4.3.3 addressing convergence
The free energy space associated to these calculations is remarkably large, espe-
cially when the auxiliary domains are included and with them four collective
variables are involved. Hence, quantifying the extent to which this highly-
dimensional space has been explored may represent a useful orientation tool
before analyzing the results. In the case of the kinase domain, where the CVs
were two, we claim convergence was attained by observing that the hills’ height
goes smoothly to zero (see figure 19), in agreement with the well-tempered
metaD scheme. We divided the free energy space in elements of volume of the
size of ten times the gaussian width and counted how many of these hyper-
cubes where visited since 600 ns until the end of the simulation at 1µs: the
visited volume results 97% of the total.
The matter changes for the systems including the auxiliary domains. In this
case, the free energy space has two more dimensions, so two orders of magni-
tude more of hyper-cubes to visit. The same quantity, the percentage of volume
visited by the system, drops to 36% for the SH2 + kinase domain and 31% for
the SH3 + SH2 + kinase domain. The hills’ height also reflects some distance
from the condition of full exploration of the free energy space. Yet, we can add
to this picture that the main part of the non-explored space is arguably ascrib-
able to the large portion of the solid angle allowed by the full extension of the
linker to the detached group of the auxiliary domains. For our purposes, the
free energy profile in the dimension of CV3 and CV4 features a large entropic
minimum that is as highly degenerate in free energy as large to fully explore.
This minimum is already present in the free energy profiles we present, to-
gether with the other two conformations of interest, with SH2 docked at one of
the two interfaces. Thus, all the conformations we were interested to correlate
are present in the trajectories we present and discuss here. Completion of a
uniform sampling of the free energy space will possibly confirm or provide
quantitative adjustments to the considerations these simulations already allow
and that we now proceed to describe.
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Figure 19: Comparison of the metaD gaussians’ height of the simulation at 310 K for the three systems.
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4.4 results and discussion
4.4.1 evolution of the trajectories at 310 k
This first block of results responds to a descriptive intention. Here I describe
the details of the evolution of the three trajectories that compose this study by
looking at each CV separately, for each trajectory. The plots under discussion
are collected in the appendix, starting from p.79. The aim is helping the vi-
sualization of the actual sequence of conformational events that the systems
undergo that are the basis of the discussion contained in the next sections. The
simulation of the only kinase domain obviously lacks the CV that refer to the
auxiliary gear.
The aim of adding two CVs triggering SH2 detachment and attachment to the
two interfaces was elucidating the physical role of the auxiliary domains in ac-
tivation and downregulation. Although, this came at the price of enlarging by
two orders of magnitude the configurational space to sample, with the conse-
quences described at §4.3.3. We remark that, in both simulations including the
auxiliary domains, the goal of modeling the conformational transition between
the two extremes has been reached, at least qualitatively. In fact, if we observe
the plots that refer to CV3 and CV4 of the simulation of SH2 + kinase domain
(fig. 35 and 37), the auxiliary module samples repeatedly the N-lobe interface,
while in the homologous case of the same CVs for SH3 + SH2 + kinase domain
(fig. 36 and 38) this happens with much more rarity. This fact is definitely
caused by the presence of SH3 and its interactions with the linker that result
in a consistent hindrance to the full extension of the linker and the attached
domains. We will give to this occurrence appropriate space in the next para-
graph, as it reflects a constitutive characteristic of the full-length protein with
a heavy impact on the overall dynamics of the system.
Having anticipated this with the aim of making the interpretation of the re-
sults easier, we present here the evolution of each of the individual variables
during the course of the simulation. The upper panel plots the CV values at
each step of the simulation and give a graphical intuition of its evolution. The
lower panel depicts the relative free energy profile at regular time intervals.
Additionally, the plots include the values in the CV space for the native ref-
erence structures. In the case of the path collective variables, values of those
structures that were used to build the CV, namely as frames for the CV defi-
nition, appear in the plots as golden lines. Similarly, in the plots of CV3 and
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CV4 useful reference values are shown respectively in gold and turquoise in
the upper panel, and in gold in the lower panel. In all other cases, the native
CV value is traced in gray. It can seem surprising to see, in some cases, that
the lines corresponding to the native structures fall close, yet not inside the
native minimum that we associate to them. This is particularly evident for
path-based collective variables and can be explained by recalling that a crystal-
lographic protein structure always expresses an average conformation and, in
this particular case, each native structure included in the topology represents
an ideal extreme, that results from relaxation and minimization in vacuum. Be-
ing a protein inherently dynamic, it is definitely only a fraction of the native
contacts, even of those from the same conformation, that is maintained under
the influence of a Langevin dynamics at 310 K (our choice to computationally
mimic the surrounding biological environment). Since path-based variables
depend on a large number of atomic distances deriving from a static conforma-
tion, this measure is particularly sensitive to every native contact that detaches
from its static definition. In consideration of this, we consider this aspect not
problematic and nonetheless consider these structures as highly representative
for the underlying topology, and graphically indicative of a tendency.
4.4.2 comparative analysis of one dimensional free energy pro-
files
Finally, in the following we expose the results of the comparison of the homol-
ogous free energy profiles of all systems. For the sake of clarity, I discuss each
structural element separately. It is most convenient to start from the discussion
of the auxiliary domains because their arrangement enters the discussion of
other variables.
regulatory domains Simulations of the multidomain constructs reveal
an essential trait added by SH3 in the dynamics of c-Abl: a drop in the fre-
quency of SH2 ligation to the N-lobe. A primary role in this issue is played
by the strength of intermolecular interactions between SH3 and the linker de-
scribed in §4.2.2. These interactions lock the strand SH3-SH2-linker in a folded,
hairpin-like arrangement and consequently confines the domains to a limited
range of movement. It is only when these interactions are released that the
linker can extend completely and that the N-lobe interface enters within reach
of SH2. When, on the other hand, interactions between linker and SH3 are
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effective, SH2 experiences a heavy and indirect restraint to its motion. This
limitation acts, if not exclusively by pressing SH2 onto the C-lobe interface, by
restricting the motion range around it and creates an overall statistical advan-
tage for the autoinhibited arrangement. In a less idealized picture, molecular
crowding should also be counted as an additional factor affecting the domains’
movement between the transition extremes. These observations align with the
idea of a protein design that is strongly oriented towards autoinhibition by en-
forcing conditions that efficiently hinder the fully active conformation at a low
energetic and evolutionary cost. In this light, then, the comparative scheme we
are presenting elucidates a powerful dynamical artifice through which c-Abl
achieves the strict downregulation central to its physiology.
Both CV3 and CV4 (in fig. 20 and 21) give a clear description of the dynamics
of the system and map into clear free energy profiles with multiple minima
that are easily associated to the conformations of interest (the inactive confor-
mation with SH2 at the C-lobe, at low values of CV3 and high values of CV4,
the active conformation with SH2 at the N-lobe, vice versa, and finally a large
entropic minimum at the largest distance for both CVs that corresponds to all
other conformations that hold no functional relevance to the extent of SH2 ar-
rangement). The inequality in sampling of SH2 at the N-lobe we alluded to for
the previous collective variables emerges most clearly here.
From a quantitative point of view, the balancing between the minima depends
critically on the exhaustive sampling of the free energy space and drawing
quantitative conclusions seems premature at this point.
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Figure 20: Comparison of the final free energy profiles for CV3 (distance from SH2 lower interface).
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Figure 21: Comparison of the final free energy profiles for CV4 (distance from SH2 higher interface).
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activation loop Comparison of the three free energy profiles for the acti-
vation loop (fig.22 and table 7) shows that, while in the kinase domain the open
conformation has a higher free energy of 6.3 kJ/mol than the closed one, the
difference in free energy between the two basins ∆∆Gopen→closed falls for both
around zero kJ/mol when at least one auxiliary domain is included. The dif-
ference between ∆∆Gopen→closed for the two systems is within RT (2.6 kJ/mol)
(here and in the following we take RT as the minimal threshold to consider
reliable a difference in free energy). Keeping in mind the caution of the RT
threshold, we also remark, when only SH2 is present, a slight inversion in the
balance between conformations. This may hint to a change of global minimum,
with the open loop taking this role, at variance with other systems in which
the closed one seems to be statistically preferential.
The energy barrier for the converged calculation of the kinase domain is found
at 8.9 kJ/mol. For the multidomain systems, these values are 8.6 kJ/mol for
the second system (SH2+kd) and 13.5 kJ/mol for the largest one.
kd SH2 + kd SH3 + SH2 + kd
∆∆Gopen→closed
[ kJ/mol ] -6.3 0.7 -0.8
Barrier height from global minimum
[ kJ/mol ] 8.9 8.6 13.5
Table 7: Highlights of the comparison of the final free energy profiles for CV1
(s-path on aloop), shown in fig. 22.
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Figure 22: Comparison of the final free energy profiles for CV1 (s-path on aloop).
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dfg motif The DFG-in state steadily occupies the global minimum in all sim-
ulations and is then consistently recovered as the most favorable conformation
with respect to the DFG-out. This is clearer in the free energy profile of the
first extracted and reweighted variable (the distance Ile 312 CG1 - Asp 400 CG,
fig. 23). The path variable CV2 rather served successfully to induce the DFG
transition (fig. 24) in the metaD framework. This finding agrees qualitatively
with all previous indications from classical force field and other non-structure-
based methods (see page 41) on the balance between the two DFG orientations.
Again, engagement of the SH2 and SH3 has a remarkable effect on the popula-
tions that results in free energy differences beyond RT. Only SH2 + kd exhibits
a minimum for the DFG out conformation (with ∆∆Gin→out = 4 kJ/mol), where
the kinase domain reveals a plateau at 9.9 kJ/mol and the system starting at
SH3 shows a descending and rather steep profile at 13.0 kJ/mol at the same
coordinate. Here, then, we face divergent outcomes, leaving the profile for the
kinase domain lying halfway between the other two. Given the design of this
experiment, this result can easily reflect the different engagement of the adap-
tor domains, although this remains to be confirmed at the conclusion of the
calculations. It is clear in fact that SH2 + kd spans the transition state for the
SH2 displacement more effectively than the third system and this fact may be
having an impact here. In this sense, our data support an higher occurrence of
the DFG flip and a stabilization of the DFG Asp out orientation in the case of
a more efficient drift of the regulatory domains. This notion will find further
support when we will discuss the motion of the lobes’ hinge.
kd SH2 + kd SH3 + SH2 + kd
Energy at DFG Asp out plateau ∆∆Gin→out descending curve
[ kJ/mol ] 9.9 -4.0 13.0
Barrier height from global minimum
[ kJ/mol ] / 9.6 /
Table 8: Highlights of the comparison of the final free energy profiles for the
DFG, shown in fig. 23 and 24.
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Figure 23: Comparison of the final free energy profiles for the extracted distance ILE312 CG1 - ASP400
CG (DFG, out→ in).
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Figure 24: Comparison of the final free energy profiles for of CV2 (s-path on DFG).
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abl-like and src-like inactivation modes Two distances were ex-
tracted and reweighted to investigate the concerted path that critical amino
acids follow when assuming the active and the inactive conformations referred
to as Abl- and Src-like during its catalytic cycle, and to reveal if this conforma-
tional transition is functionally coupled to others in the domain arrangement.
Regarding the fundamental ion pair between Lys 290 in the active site and
Glu 305 from the αC helix (fig. 25), neither a clearly defined transition state
nor any meaningful difference among the profiles can be distinguished and we
conclude that this observable appears unaffected by the other structural factors
we considered.
With respect to the salt bridge with Arg 405 that exposes Glu 305 to the sol-
vent in the Src-like inactive conformation (figure 26), the SH2+kinase domain
system profile leans towards the extreme of the transition at low distance, re-
sulting in a significantly lower extreme at short distance with respect to the
kinase domain and SH3+SH2+kd. This points to an influence of SH2 in this
motion, in the sense that SH2 at the N-lobe or unligated may disfavor the salt
bridge in question.
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Figure 25: Comparison of the final free energy profiles for extracted distance Lys 290 NZ - Glu 305 CD
(active site, active→ Abl-like inactive).
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Figure 26: Comparison of the final free energy profiles for extracted distance Glu 305 CD - Arg 405 CZ
(external salt bridge, Src-like inactive→ any other state)
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Auxiliary domains in 
autoinhibited conformation
Detached
auxiliary domains 
Auxiliary 
domains in 
activated 
conformation
Figure 27: Examples of lobes separation, a quantity rooted in the hinge flexion
that was measured through the distance Val 299 CA - Tyr 432 CA.
These atoms are highlighted in fuchsia and the relative residue is
shown in yellow. A possible correlation with the position of the
auxiliary domains emerges in the discussed simulations.
hinge motion To measure this choral and subtle movement described at
page 41, the distance Val 299 CA - Tyr 432 CA was chosen (see fig. 27 for a
visualization and fig. 28 for the final free energy plots). Even at eyesight is ev-
ident that the average distance spanned by SH3+SH2+kd is lower than for the
other systems. In fact, the width of its profile when crossing an ideal reference
line of 5 kJ/mol is of 5.7 Å against 7.3 Å for both other systems. Thus, again
in agreement with the experimental indications, the hinge motion is indeed
limited when the autoinhibited conformation is most often visited. Moreover,
the hinge motion curve leans towards lower values for SH2+kd in comparison
with other systems. The presence and behavior of SH2 may then contribute to
reduce the average separation between the lobes. As a result, another contri-
bution to c-Abl autoinhibitory strategy has been consistently revealed by the
model and shows potential of further insight into c-Abl machinery.
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Figure 28: Comparison of the final free energy profiles for extracted hinge motion measure (distance Val
299 CA - Tyr 432 CA).
75
4 Conformational transitions in c-Abl
4.5 concluding remarks
The computational approach and the application we described compose known
experimental notions and theoretical concepts with the goal of describing the
interplay of conformational transitions driving c-Abl. To the extent allowed
by the advancement of the simulations, we have shown that the presence, lo-
calization and dynamics of the auxiliary modules results in quantitative and
qualitative differences in the free energy profiles corresponding to conforma-
tional changes in several structural elements in c-Abl. Their contribution has
primary importance in determining the key balance of populations needed for
proper function, and represents a proof of concept of the crucial, quantifiable
relevance of the regulatory domains in the action of the catalytic core they
serve.
Here we summarize the conclusions reached in this discussion:
• The articulate movement of the auxiliary domains in this simulations elu-
cidates in dynamical details the primary role of the SH3 domain in c-Abl
autoinhibition: by establishing intermolecular interactions with the linker,
it keeps the whole auxiliary apparatus (composed by the linker + SH2 +
SH3) blocked in a limited range of movement around the autoinhibiting
conformation.
• For the system featuring SH2 but not SH3, with the previous effect thus
removed by construction, an highly enhanced detachment and drift of the
auxiliary gear (SH2 and linker) was revealed, that cascades in enhanced
binding to the activating N-lobe interface and distinctly evidences the
downregulating effect of SH3 in full length c-Abl.
• When SH2 is bound to the C-lobe, the lobes average separation is consis-
tently low. As a consequence, the results also let infer that SH2 detach-
ment from the C-lobe interface appears associated to other transitions:
the activation loop opening and closing, the DFG flip and hinge motion
opening.
• No specific correlation was isolated in the salt bridges underpinning Src
and Abl like inactivation.
The combination of the structure-based approach and parallel tempering meta-
dynamics sampling boosted the insight potential of the model to its maximum.
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By rationally choosing and merging available informations, we built a tool
whose descriptive power goes beyond the sum of its elements and gained
unique insight into protein regulation. In perspective, this approach holds
the promise of helping the rational description and the revelation of still hid-
den vulnerabilities in the regulation of whole proteins, and to contribute in this
way to advance biomedical progress.
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C O N C L U S I O N E S
El protocolo que hemos descrito anteriormente se compone tanto de nociones
experimentales como de conceptos teóricos que se engloban en un esquema in-
novador, cuyo principal objetivo es describir la interacción de las transiciones
conformacionales producidas en la proteína c-Abl. En la medida que el avance
de las simulaciones nos permite, hemos demostrado que la presencia, local-
ización y dinámica de los módulos auxiliares añaden diferencias cuantitativas
y cualitativas en los perfiles de energía libre con respecto a numerosos elemen-
tos estructurales de los sistemas simulados de la proteína c-Abl.
Así mismo se demuestra como la contribución de dichos módulos tiene gran
importancia a la hora de determinar el equilibrio de las poblaciones conforma-
cionales que es indispensable para que una proteína exprese correctamente su
papel biológico. Y por último, este trabajo representa una prueba de concepto
de la relevancia crucial y cuantificable de los dominios auxiliares en la acción
del dominio catalítico al que sirven.
Al haber escogido y conjugado racionalmente información públicamente ac-
cesible, modelización basada en la estructura y los cálculos de metadinámica a
temperaturas paralelas (conocida como parallel tempering metadynamics) hemos
construido una herramienta cuyo poder descriptivo va más allá de la suma de
sus elementos, adquiriendo una visión única de la regulación de la proteína
c-Abl.
En perspectiva, este enfoque nos brinda la posibilidad de describir racional-
mente la dinámica de proteínas completas, con el fin de revelar vulnerabil-
idades estructurales en las que se basen tanto las enfermedades como los
tratamientos farmacológicos (como en el caso de c-Abl), y ofreciéndonos de
esta manera un gran potencial de contribuir a promover el progreso biomédico
hacía nuevos éxitos.
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evolution of the trajectories at 310 k
The following plots refer to §4.4.1, where an overview on the contents of this
appendix can be found. These plots show, in the upper panel, the monitoring
of each CV of the three trajectories, and the evolving free energy surface that
results from it in the lower panel.
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Figure 29: Kinase domain. Evolution along simulation time of CV1 (s-path on aloop, upper panel) and of its free energy landscape (lower panel) at
310 K.
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Figure 30: SH2 + Kinase domain. Evolution along simulation time of CV1 (s-path on aloop, upper panel) and of its free energy landscape (lower panel)
at 310 K.
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Figure 31: SH3 + SH2 + Kinase domain. Evolution along simulation time of CV1 (s-path on aloop, upper panel) and of its free energy landscape (lower
panel) at 310 K.
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Figure 32: Kinase domain. Evolution along simulation time of CV2 (s-path on DFG, upper panel) and of its free energy landscape (lower panel) at 310
K.
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Figure 33: SH2 + Kinase domain. Evolution along simulation time of CV2 (s-path on DFG, upper panel) and of its free energy landscape (lower panel)
at 310 K.
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Figure 34: SH3 + SH2 + Kinase domain. Evolution along simulation time of CV2 (s-path on DFG, upper panel) and of its free energy landscape (lower
panel) at 310 K.
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Figure 35: SH2 + Kinase domain. Evolution along simulation time of CV3 (distance from SH2 lower interface, red in the upper panel, where CV4 is
also shown in green) and of its free energy landscape (lower panel) at 310 K.
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Figure 36: SH3 + SH2 + Kinase domain. Evolution along simulation time of CV3 (distance from SH2 lower interface, red in the upper panel, where
CV4 is also shown in green) and of its free energy landscape (lower panel) at 310 K.
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Figure 37: SH2 + Kinase domain. Evolution along simulation time of CV4 (distance from SH2 higher interface, green in the upper panel, where CV3
is also shown in red) and of its free energy landscape (lower panel) at 310 K.
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Figure 38: SH3 + SH2 + Kinase domain. Evolution along simulation time of CV4 (distance from SH2 higher interface, green in the upper panel, where
CV3 is also shown in red) and of its free energy landscape (lower panel) at 310 K.
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Figure 39: Kinase domain. Evolution along simulation time of the extracted distance ILE312 CG1 - ASP400 CG (DFG, out → in; upper panel) and of
its free energy landscape (lower panel) at 310 K.
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Figure 40: SH2 + Kinase domain. Evolution along simulation time of the extracted distance ILE312 CG1 - ASP400 CG (DFG, out → in; upper panel)
and of its free energy landscape (lower panel) at 310 K.
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Figure 41: SH3 + SH2 + Kinase domain. Evolution along simulation time of the extracted distance ILE312 CG1 - ASP400 CG (DFG, out → in; upper
panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 42: Kinase domain. Evolution along simulation time of the extracted distance Lys 290 NZ - Glu 305 CD (active site, active → Abl-like inactive;
upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 43: SH2 + Kinase domain. Evolution along simulation time of the extracted distance Lys 290 NZ - Glu 305 CD (active site, active → Abl-like
inactive; upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 44: SH3 + SH2 + Kinase domain. Evolution along simulation time of the extracted distance Lys 290 NZ - Glu 305 CD (active site, active →
Abl-like inactive; upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 45: Kinase domain. Evolution along simulation time of the extracted distance Glu 305 CD - Arg 405 CZ (external salt bridge, Src-like inactive
→ any other state; upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 46: SH2 + Kinase domain. Evolution along simulation time of the extracted distance Glu 305 CD - Arg 405 CZ (external salt bridge, Src-like
inactive→ any other state; upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 47: SH3 + SH2 + Kinase domain. Evolution along simulation time of the extracted distance Glu 305 CD - Arg 405 CZ (external salt bridge,
Src-like inactive→ any other state; upper panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 48: Kinase domain. Evolution along simulation time of the extracted hinge motion measure (distance Val 299 CA - Tyr 432 CA, upper panel)
and of its free energy landscape (lower panel) at 310 K.
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Figure 49: SH2 + Kinase domain. Evolution along simulation time of the extracted hinge motion measure (distance Val 299 CA - Tyr 432 CA, upper
panel) and of its free energy landscape (lower panel) at 310 K.
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Figure 50: SH3 + SH2 + Kinase domain. Evolution along simulation time of the extracted hinge motion measure (distance Val 299 CA - Tyr 432 CA,
upper panel) and of its free energy landscape (lower panel) at 310 K.
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